Washington testing vaccine Volunteers Washington

Novavax begins Phase 3 testing of COVID-19 vaccine candidate

Reading now: 880
www.fox29.com

WASHINGTON (AP) - A huge study of another COVID-19 vaccine candidate is getting underway Monday as states in the U.S.

continue to roll out scarce supplies of the nation’s first shot options.The U.S. has authorized emergency use of two vaccines, one made by Pfizer and BioNTech and the other by Moderna, but doses will be rationed for months.The candidate made by Novavax Inc.

is the fifth to reach final-stage testing in the U.S. Some 30,000 volunteers are needed to prove if this vaccine — a different kind than its Pfizer and Moderna competitors — really works and is safe.RELATED: Volunteers still needed to test variety of coronavirus vaccinesThe study, which is funded by the U.S.

Read more on fox29.com
The website covid-19.rehab is an aggregator of news from open sources. The source is indicated at the beginning and at the end of the announcement. You can send a complaint on the news if you find it unreliable.

Related News

DMCA